Next-Generation Sequencing
NGS-based diagnostic assays for oncology and infectious disease — currently in development under our R&D programme.
Future Pipeline
What's next for Gene Matrix.
A look at the assays and platforms currently in development. The capabilities described on this page are not yet available for clinical use.
Currently in development
The items on this page are part of Gene Matrix's R&D pipeline. They are not currently available for purchase, clinical use, or distribution. For our currently available kits, see the Diagnostics portfolio.
Advanced Diagnostic Devices
Integrated platform devices designed to extend the Gene Matrix portfolio beyond reagents, in development.
Expanded Multiplex Assays
Additional multiplex PCR panels addressing further clinical priorities across infectious disease and oncology.
